J
Jong Hyun Kim
Researcher at Samsung Medical Center
Publications - 54
Citations - 1526
Jong Hyun Kim is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Radiosurgery & Meningioma. The author has an hindex of 22, co-authored 54 publications receiving 1415 citations.
Papers
More filters
Journal ArticleDOI
Prognostic significance of c-Met expression in glioblastomas.
Doo-Sik Kong,Sang-Yong Song,Duk-Hwan Kim,Kyeung Min Joo,Jin-San Yoo,Jong Sung Koh,Seung Myung Dong,Yeon-Lim Suh,Jung-Il Lee,Kwan Park,Jong Hyun Kim,Do-Hyun Nam +11 more
TL;DR: The authors investigated whether expression of c‐Met protein in glioblastomas is associated with overall survival and biologic features representing tumor invasiveness in patients with gliOBlastomas.
Journal ArticleDOI
Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas
TL;DR: The objective of this prospective cohort study was to determine the efficacy of stereotactic radiosurgery as a salvage treatment in patients with recurrent malignant gliomas.
Journal ArticleDOI
The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
Doo-Sik Kong,Jung-Il Lee,Do Hoon Lim,Kwang Won Kim,Hyung Jin Shin,Do-Hyun Nam,Kwan Park,Jong Hyun Kim +7 more
TL;DR: The objective of this retrospective cohort study was to define the efficacy and safety of fractionated radiotherapy (FRT) and stereotactic radiosurgery (SRS) for the treatment of patients with pituitary adenoma.
Journal ArticleDOI
Treatment of atypical meningioma.
TL;DR: In this series, complete resection of the tumor is a key determinant for a better outcome and adjuvant radiation therapy is recommended if incomplete surgical excision is performed.
Journal ArticleDOI
Relationship between malignant subtypes of meningioma and clinical outcome.
TL;DR: It is suggested that all meningiomas should be evaluated for malignancy and the extent of surgical resection, the histological subtype, and the Ki-67 index can help to predict the clinical outcome forMeningioma patients.